RBC Capital Maintains Outperform on Xylem, Raises Price Target to $140
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Deane Dray has maintained an Outperform rating on Xylem (NYSE:XYL) and increased the price target from $120 to $140.
January 04, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Deane Dray maintains an Outperform rating on Xylem and raises the price target from $120 to $140, indicating a positive outlook on the stock.
The increase in price target by RBC Capital suggests a bullish outlook on Xylem's future performance, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100